SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-006122
Filing Date
2021-03-16
Accepted
2021-03-16 16:43:19
Documents
79
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1227391
2 ex4-6.htm EX-4.6 27088
3 ex10-11.htm EX-10.11 186662
4 ex23-1.htm EX-23.1 3722
5 ex31-1.htm EX-31.1 12725
6 ex31-2.htm EX-31.2 12520
7 ex32-1.htm EX-32.1 8755
  Complete submission text file 0001493152-21-006122.txt   5982907

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE eton-20201231.xml EX-101.INS 797196
9 XBRL SCHEMA FILE eton-20201231.xsd EX-101.SCH 69308
10 XBRL CALCULATION FILE eton-20201231_cal.xml EX-101.CAL 68980
11 XBRL DEFINITION FILE eton-20201231_def.xml EX-101.DEF 309159
12 XBRL LABEL FILE eton-20201231_lab.xml EX-101.LAB 507518
13 XBRL PRESENTATION FILE eton-20201231_pre.xml EX-101.PRE 397613
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38738 | Film No.: 21746449
SIC: 2834 Pharmaceutical Preparations